Developing National Industry for the Benefit of Human Health
Developing National Industry for the Benefit of Human Health
Haotai Health
Developing National Industry for the Benefit of Human Health
Founded in 2018 with a registered capital of RMB 50 million, Jilin Haotai Health Industry Development Co., Ltd. is headquartered in Changchun, Jilin Province. It is a comprehensive high-tech enterprise specialized in the research and development, production and sales of biomedical and health products, boasting the qualification of National High-Tech Enterprise and being listed on Jilin Provincial Stock Exchange with the stock code 520023.
The company focuses on two core product categories: animal-derived extracts and Changbai Mountain plant-derived extracts. Its key animal-derived products include heparin, enoxaparin, and low molecular weight heparin, bovine liver extract, bovine prostate extract , porcine lung extract. Benefiting from the unique botanical resources of Changbai Mountain, its plant extract portfolio covers ginseng polysaccharides, ginseng oligosaccharides, and ganoderma lucidum extracts, serving the biomedical and health product industries. The company has completed 15 technological achievement transformations, with an annual average of 5. It holds 12 valid intellectual property rights (9 invention patents, 3 utility model patents), 7 novelty search reports, 5 registered trademarks and 1 copyright, providing solid technical support for product development and production.
BRAND
Time of establishment
Registered capital
Effective Intellectual Property
Floor area approx.
Cultural Concept
Development of national industry
Benefit human health
CULTURE
Develop National Industries To Benefit Human Health
Product
Wild Celery & Chlorella Granules
Mountain celery and chrysanthemum extract tablet
Mountain celery and chrysanthemum extract granules
Bovine Prostate Extract Powder
Ginseng Polysaccharides(Food/Pharma grade)
Developing National Industry for the Benefit of Human Health
Blog
Follow us and see the latest developments.
Jilin Haotai Health Industry Development Co., Ltd. participated in the 23rd World Pharmaceutical Raw Materials China Exhibition. On the first day of the exhibition, it received a total of 27 well-known brand enterprises and more than 6,000 visitors from Russia, India, South Korea, Iran, Egypt, the Netherlands, the UK, Germany, France, Belgium, Italy, Switzerland, Spain and other countries.
06-24
Jilin Haotai Health Industry Development Co., Ltd. is exhibiting at the 23rd China International Pharmaceutical Ingredients Exhibition. On the first day of the exhibition, the company welcomed a total of 27 well-known brand enterprises and over 6,000 visitors from Russia, India, South Korea, Iran, Egypt, the Netherlands, the United Kingdom, Germany, France, Belgium, Italy, Switzerland, and Spain.
06-24
Recently, the Jilin Equity Exchange officially released the list of “Specialized, Fine, and New” enterprises for 2024 in Jilin Province. Jilin Haotai Health Industry Development Co., Ltd. has successfully been included on this list thanks to its professional expertise and innovative strengths in the health sector, becoming one of the 52 companies featured. The company’s dedicated board code on the Jilin Exchange is 810016.
03-04
Contact Us
Company Address:Jilin Huinan Economic Development Zone
Tel:0086-435-5035096
E-mail:sales@jlhaotai.com
Message feedback
Please leave your needs and we will contact you as soon as possible!